Ahsan Tasnim, Rani Bharta, Siddiqui Roomana S, Lutfi Irfan
Internal Medicine: Diabetes & Endocrinology, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Internal Medicine, Diabetes and Endocrinology, Jinnah Postgraduate Medical Centre, Medicell Institute of Diabetes Endocrinology & Metabolism (MIDEM), Karachi, PAK.
Cureus. 2021 Aug 29;13(8):e17531. doi: 10.7759/cureus.17531. eCollection 2021 Aug.
The pandemic of coronavirus 19 (COVID-19) infection has presented the clinicians with a challenge never experienced on this scale before. Although coagulopathy has been well described in association with COVID-19 infection, some recommendations have emerged so far for the potential role of empiric anticoagulation in specific situations. We describe a case of a middle-aged male with extensive acute lower limb ischemia and severe pneumonia related to COVID-19 infection. This case highlights the role of prophylactic anticoagulation in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection regardless of co-morbidities and D- dimer levels.
新型冠状病毒19（COVID-19）感染的大流行给临床医生带来了前所未有的挑战。尽管已经对与COVID-19感染相关的凝血病进行了充分描述，但到目前为止，已经出现了一些关于经验性抗凝在特定情况下潜在作用的建议。我们描述了一例与COVID-19感染相关的广泛性急性下肢缺血和严重肺炎的中年男性病例。该病例强调了预防性抗凝在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中的作用，无论是否存在合并症和D-二聚体水平如何。
